Anti-IL-22 (median: 262.8 vs.190.5, p = 0.0418) antibody was decreased whereas anti-IL-15 (median: 25.5 vs. 30.5, p = 0.0069) was increased in psoriasis patients compared to that in healthy controls. Here, IL15 is linked to psoriasis.